Who
Erin Pennock Foff
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, MapLight Therapeutics.
In numbers
- Trades disclosed
- 57
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $6.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 27 Oct 2025
- Last trade
- 15 Oct 2026
- Last filed
- 16 Oct 2026
Companies traded
Activity over time
1 Apr – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Oct 2026filed 16 Oct 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $124K15,355 at $8.08 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,360 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,240 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —54,240 at $0.00 | filing |
| 17 Aug 2026filed 19 Aug 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,360 at $0.00 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $139K3,656 at $37.90 | filing |
| 17 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $139K3,656 at $37.90 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $334K9,163 at $36.46 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $219K5,865 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $72119 at $37.96 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $334K9,163 at $36.46 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $219K5,865 at $37.26 | filing |
| 16 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $72119 at $37.96 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $259K7,155 at $36.16 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $291K7,845 at $37.04 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $161K4,465 at $36.00 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $332K8,972 at $36.99 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $67618 at $37.54 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $259K7,155 at $36.16 | filing |
| 15 Jul 2026filed 17 Jul 2026 | MPLT MapLight TherapeuticsBiotechnology | SEC FORM 4 Sold | $291K7,845 at $37.04 | filing |
News
No headline names them, or the companies they trade most, lately.